540 related articles for article (PubMed ID: 27775195)
1. 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographically short cervix: A randomized controlled trial.
Pirjani R; Heidari R; Rahimi-Foroushani A; Bayesh S; Esmailzadeh A
J Obstet Gynaecol Res; 2017 Jan; 43(1):57-64. PubMed ID: 27775195
[TBL] [Abstract][Full Text] [Related]
2. Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial.
Facchinetti F; Vergani P; Di Tommaso M; Marozio L; Acaia B; Vicini R; Pignatti L; Locatelli A; Spitaleri M; Benedetto C; Zaina B; DʼAmico R
Obstet Gynecol; 2017 Jul; 130(1):64-70. PubMed ID: 28594783
[TBL] [Abstract][Full Text] [Related]
3. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
[TBL] [Abstract][Full Text] [Related]
4. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety.
El-Refaie W; Abdelhafez MS; Badawy A
Arch Gynecol Obstet; 2016 Jan; 293(1):61-67. PubMed ID: 26044148
[TBL] [Abstract][Full Text] [Related]
5. [Is universal screening for cervical length among singleton pregnancies with no history of preterm birth justified?].
Rozenberg P
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1337-1345. PubMed ID: 28166925
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of midtrimester short cervix interventions is conditional on intraamniotic inflammation.
Kiefer DG; Peltier MR; Keeler SM; Rust O; Ananth CV; Vintzileos AM; Hanna N
Am J Obstet Gynecol; 2016 Feb; 214(2):276.e1-276.e6. PubMed ID: 26364833
[TBL] [Abstract][Full Text] [Related]
7. Comparison the efficacy of vaginal progesterone
Alavi A; Ranjbar A; Atighpoor F; Zare S
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7438-7444. PubMed ID: 34470137
[TBL] [Abstract][Full Text] [Related]
8. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
O'Brien JM; Lewis DF
Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
[TBL] [Abstract][Full Text] [Related]
9. Cerclage, progesterone and α-hydroxyprogeterone caproate treatment in women at risk for preterm delivery.
Haram K; Mortensen JH; Morrison JC
J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1710-5. PubMed ID: 24678618
[TBL] [Abstract][Full Text] [Related]
10. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
[TBL] [Abstract][Full Text] [Related]
11. Treatment options and recommendations to reduce preterm births in women with short cervix.
Slager J; Lynne S
J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
[TBL] [Abstract][Full Text] [Related]
12. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V
Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
[TBL] [Abstract][Full Text] [Related]
13. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with cervical pessary and vaginal progesterone for the prevention of preterm birth: A randomized clinical trial.
Karbasian N; Sheikh M; Pirjani R; Hazrati S; Tara F; Hantoushzadeh S
J Obstet Gynaecol Res; 2016 Dec; 42(12):1673-1679. PubMed ID: 27718280
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?].
Martinez de Tejada B; Othenin-Girard V; Irion O
Rev Med Suisse; 2015 Oct; 11(492):2004, 2006-8, 2010. PubMed ID: 26672179
[TBL] [Abstract][Full Text] [Related]
16. Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface.
Furcron AE; Romero R; Plazyo O; Unkel R; Xu Y; Hassan SS; Chaemsaithong P; Mahajan A; Gomez-Lopez N
Am J Obstet Gynecol; 2015 Dec; 213(6):846.e1-846.e19. PubMed ID: 26264823
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix.
Keeler SM; Kiefer D; Rochon M; Quinones JN; Novetsky AP; Rust O
J Perinat Med; 2009; 37(5):473-9. PubMed ID: 19492920
[TBL] [Abstract][Full Text] [Related]
18. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial.
Senat MV; Porcher R; Winer N; Vayssière C; Deruelle P; Capelle M; Bretelle F; Perrotin F; Laurent Y; Connan L; Langer B; Mantel A; Azimi S; Rozenberg P;
Am J Obstet Gynecol; 2013 Mar; 208(3):194.e1-8. PubMed ID: 23433324
[TBL] [Abstract][Full Text] [Related]
19. Relation of body mass index to frequency of recurrent preterm birth in women treated with 17-alpha hydroxyprogesterone caproate.
Co AL; Walker HC; Hade EM; Iams JD
Am J Obstet Gynecol; 2015 Aug; 213(2):233.e1-5. PubMed ID: 25912300
[TBL] [Abstract][Full Text] [Related]
20. Should phenotype of previous preterm birth influence management of women with short cervix in subsequent pregnancy? Comparison of vaginal progesterone and Arabin pessary.
Care A; Muller-Myhsok B; Olearo E; Todros T; Caradeux J; Goya M; Palacio M; Carreras E; Alfirevic Z
Ultrasound Obstet Gynecol; 2019 Apr; 53(4):529-534. PubMed ID: 29920812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
